Perrigo Company plc ( PRGO) - Key Metrics
PRGO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $7.35 | $0.54 | $0.99 | $0.89 |
| 2026Q1 | $6.99 | -$2.87 | -$0.82 | -$0.92 |
| 2025Q4 | $8.01 | -$10.24 | $1.27 | $1.07 |
| 2025Q3 | $7.53 | $0.05 | $0.37 | $0.22 |
| 2025Q2 | $7.64 | -$0.06 | $0.55 | $0.41 |
PRGO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 107.52% | 4.61 |
| 2026Q1 | -10.01% | -0.83 |
| 2025Q4 | -2.81% | -0.34 |
| 2025Q3 | 532.00% | 98.94 |
| 2025Q2 | -463.10% | -109.13 |
PRGO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 8.96% | 5.79% |
| 2026Q1 | -9.64% | 3.02% |
| 2025Q4 | 7.71% | 2.07% |
| 2025Q3 | 1.00% | 1.34% |
| 2025Q2 | 1.55% | 1.06% |
PRGO
List: Challengers
Price: $14.92
Dividend Yield: 9.03%
Forward Dividend Yield: 7.77%
Payout Ratio: -133.01%
Dividend Per Share: 1.16 USD
Earnings Per Share: -12.10 USD
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Ireland
Volume: 680000
Ebitda: 274.7 millionMarket Capitalization: 1.7 billion
Average Dividend Frequency: 4
Years Paying Dividends: 24
DGR3: 6.74%
DGR5: 8.34%
DGR10: 10.70%
DGR20: 11.18%